Package 50771-013-01

Brand: entecavir

Generic: entecavir
NDC Package

Package Facts

Identity

Package NDC 50771-013-01
Digits Only 5077101301
Product NDC 50771-013
Product ID 50771-013_4502e388-5064-bd87-e063-6294a90a4b1c
Description

30 TABLET, FILM COATED in 1 BOTTLE (50771-013-01)

Marketing

Marketing Status
Marketed Since 2023-07-01
Brand entecavir
Generic entecavir
Sample Package No

Linked Drug Pages (1)

ENTECAVIR ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "4502e388-5064-bd87-e063-6294a90a4b1c", "openfda": {"upc": ["0350771013014", "0350771014011", "0350771013021"], "unii": ["5968Y6H45M"], "rxcui": ["485434", "485436"], "spl_set_id": ["73dea2a4-a596-477f-b66d-5a80dd019837"], "manufacturer_name": ["Yaopharma Co., Ltd."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (50771-013-01)", "package_ndc": "50771-013-01", "marketing_start_date": "20230701"}, {"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE (50771-013-02)", "package_ndc": "50771-013-02", "marketing_start_date": "20230701"}], "brand_name": "ENTECAVIR", "product_id": "50771-013_4502e388-5064-bd87-e063-6294a90a4b1c", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Analog [EXT]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "50771-013", "generic_name": "entecavir", "labeler_name": "Yaopharma Co., Ltd.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ENTECAVIR", "active_ingredients": [{"name": "ENTECAVIR", "strength": ".5 mg/1"}], "application_number": "ANDA212201", "marketing_category": "ANDA", "marketing_start_date": "20230701", "listing_expiration_date": "20261231"}